Sebastien Granier

Title: **Sebastien Granier: Innovator in GPCR Structural Biology**

Introduction

Sebastien Granier, an accomplished inventor based in Menlo Park, CA, has made significant contributions to the field of G protein-coupled receptor (GPCR) structural biology and signaling. His innovative work has led to a patent that enhances the understanding and utilization of GPCR and G protein complexes, which are crucial in various biological processes.

Latest Patents

Sebastien Granier holds a patent titled "Binding domains directed against GPCR:G protein complexes and uses derived thereof." This patent focuses on the development of binding domains specifically targeting GPCR:G protein complexes. The technology described enables researchers to utilize these binding domains as universal tools for structural and functional characterization of GPCRs. The patent also includes nucleic acid sequences for encoding these domains, enhancing their practical application in drug discovery and screening processes involving GPCR:G protein complexes.

Career Highlights

Granier has had a diverse career, working with notable organizations such as Vib Vzw and Vrije Universiteit Brussel. His role in these institutions reflects his commitment to research and innovation in the field of structural biology. His expertise has positioned him as a valuable asset in advancing the understanding of GPCR signaling mechanisms.

Collaborations

Throughout his career, Sebastien Granier has collaborated with esteemed colleagues, including Jan Steyaert and Els Pardon. These partnerships have fostered an environment of innovation, allowing for the exchange of ideas and techniques that advance their shared research goals.

Conclusion

Sebastien Granier's contributions to GPCR structural biology underscore the importance of innovation in the understanding of complex biological systems. His patent holds promise for advancing drug discovery and enhancing our comprehension of GPCR functions. As the field continues to evolve, Granier's work is likely to influence future developments in medicinal chemistry and pharmacology.